共 16 条
[1]
ACUTE AND LONG-TERM AMILORIDE INHALATION IN CYSTIC-FIBROSIS LUNG-DISEASE - A RATIONAL APPROACH TO CYSTIC-FIBROSIS THERAPY
[J].
AMERICAN REVIEW OF RESPIRATORY DISEASE,
1990, 141 (03)
:605-612
[4]
Collingwood S. P., 2009, International Patent, Patent No. [WO 150 137 A2, 150137]
[6]
THE SYNTHESIS OF ALPHA-AMINO-GAMMA-(PARA-HYDROXYPHENYL)BUTYRIC ACID, A HOMOLOGUE OF TYROSINE
[J].
JOURNAL OF THE CHEMICAL SOCIETY,
1947, (NOV)
:1571-1573
[7]
Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease
[J].
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,
2008, 325 (01)
:77-88
[8]
Aerosolized amiloride: Dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis
[J].
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG,
1996, 10 (02)
:147-158